Immuno-oncology has captured the attention of researchers and pharmaceutical industries worldwide. This promising treatment at the forefront of cancer research is already reaching patients and uses the body’s immune system to recognize, target, and eliminate tumor cells. How does the immune system precisely target cells, re-evaluate and launch new attacks if needed, and use its “memory” to target and eliminate cancer if it returns?
Join Kavita Iyer, Scientific Content Creator of ACSI India, Aik Choon Tan, Senior Director of Data Science of the Huntsman Cancer Institute at the University of Utah, and Hisham Hamadeh, Senior Vice President and Global Head of Data Science & AI at Genmab for an overview of the current immuno-oncology landscape. Register now to learn natural language processing (NLP), computational, and statistical learning methods and their current use in data mining and analysis, personalized oncology treatment, and to overcoming treatment resistance.
This ACS Webinar is moderated by Qiongqiong Angela Zhou, Manager, Scientific Analysis and Insights at CAS and is co-produced by CAS, a division of the American Chemical Society.
* If you are having technical difficulties viewing the video please try different internet browsers like Chrome, Firefox, and Explorer. If you still can not access the video please review the following computer prerequisites from our video hosting platform.
What You Will Learn
- An overview of the immuno-oncology landscape based data analysis using natural language processing from the CAS Content Collection
- Machine learning algorithmic methods for developing and validating biomarkers for personalized oncology medicine
- The importance of data sharing and use case examples of how to leverage multiple data sources
Additional Resources
- R&D Insight: Unique views into immuno-oncology - CAS Insights
- Case Studies for Overcoming Challenges in Using Big Data in Cancer - AACR article
- Biomarkers: The key to earlier cancer detection and patient outcomes - CAS article
Co-Produced With
What an attendee said about this ACS Webinar!
I have a BS in Chemistry and am currently pursuing a PhD in Biochemistry. My thesis evaluates the effectiveness and specificity of novel drugs with potential anti-metastatic effects. These compounds have also been shown to have a role in the regulation of immunity cells, so these types of Webinars are of great relevance in my development as a cancer researcher and in the understanding of my thesis project.
BECAUSE PEOPLE
LIKE YOU CREATE
GREAT CHEMISTRY
You belong here
;void(0);){kind=link}